To explore the mechanism involved in siRNA-induced toxicity on the two human prostate cancer cell lines, we studied the signaling pathway involving TLR3-mediated activation of interferon regulatory factor 3 (IRF3), which leads to release of IFNβ and generation of an inflammatory response [40]. Here, IFNB1 is linked to prostate cancer.